- Home
- NXPI vs BDX Comparison
NXPI vs BDX Comparison
Compare NXPI & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXPI | BDX |
|---|---|---|
| Founded | 2006 | 1897 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.0B | 54.6B |
| IPO Year | 2007 | 1998 |
Fundamental Metrics
Financial Performance| Metric | NXPI | BDX |
|---|---|---|
| Price | $246.89 | $212.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 30 | 16 |
| Target Price | ★ $299.93 | $195.57 |
| AVG Volume (30 Days) | ★ 4.5M | 1.7M |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | 1.66% | ★ 1.99% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.92 | 1.59 |
| Revenue | $12,269,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $16.67 | $1.39 |
| Revenue Next Year | $11.94 | $4.07 |
| P/E Ratio | ★ $24.27 | $131.57 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $183.00 | $140.11 |
| 52 Week High | $339.95 | $213.08 |
Technical Indicators
Market Signals| Indicator | NXPI | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 53.03 | 73.36 |
| Support Level | $215.97 | $175.60 |
| Resistance Level | $256.36 | $213.08 |
| Average True Range (ATR) | 12.38 | 4.32 |
| MACD | 0.50 | 1.46 |
| Stochastic Oscillator | 50.93 | 86.32 |
Price Performance
Historical ComparisonAbout NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About BDX Becton Dickinson and Company
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.